Literature DB >> 22785600

The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.

Nonanzit Pérez-Hernández1, Gilberto Vargas-Alarcón, Nancy Martínez-Rodríguez, Marco Antonio Martínez-Ríos, Marco Antonio Peña-Duque, Aurora de la Peña-Díaz, Benjamín Valente-Acosta, Carlos Posadas-Romero, Aida Medina, José Manuel Rodríguez-Pérez.   

Abstract

AIM: Was to evaluate the role of seven matrix metalloproteinase (MMP) polymorphisms in the genetic susceptibility to develop myocardial infarction in Mexican individuals.
METHODS: Seven polymorphisms in the MMP genes were genotyped by 5' exonuclease TaqMan genotyping assays in 300 patients with myocardial infarction and 300 healthy unrelated controls.
RESULTS: A similar distribution of MMP2-1306 (rs243865), MMP2-790 (rs243864), MMP2-735 (rs22850553), MMP7-153(rs11568819), MMP7-181(rs11568818), and MMP12-82(rs2276109) polymorphisms was observed in both studied groups. On the other hand, patients showed increased frequencies of MMP2-1575 A allele and AA genotype when compared to controls (pC= 0.001; OR= 1.58 and pC= 0.036; OR= 2.37, respectively). According to the dominant model, individuals with AG+AA genotypes had a 1.65-fold increased risk of developing the disease (p= 0.002). After adjusting for known risk factors, we found a significant contribution of gender, BMI, smoking habit, diabetes mellitus, and hypertension to the inheritance model. In this analysis, individuals with the-1575 AA genotype had a 4.23-fold increased risk of developing MI (p= 0.003). On the other hand, an association of the MMP12-82 polymorphism with the extent of coronary artery disease (CAD) was observed. In our study, it was possible to distinguish two risk haplotypes and one protective haplotype for this disease in the MMP2 gene.
CONCLUSIONS: The results suggest that the MMP2-1575 (rs243866) gene polymorphism could be involved in the risk of developing myocardial infarction in Mexican individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785600     DOI: 10.5551/jat.11817

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  12 in total

Review 1.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

2.  Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.

Authors:  Saeed Elahirad; Daniel Elieh Ali Komi; Amir Kiani; Ehsan Mohammadi-Noori; Asad Vaisi-Raygani; Hadi Mozafari; Fariborz Bahrehmand; Mohammadreza Saidi; Vahid Toupchi-Khosroshahi; Nahid Salehi
Journal:  Cardiovasc Toxicol       Date:  2021-11-03       Impact factor: 3.231

Review 3.  Fibroblast contributions to ischemic cardiac remodeling.

Authors:  Ryan M Burke; Kimberly N Burgos Villar; Eric M Small
Journal:  Cell Signal       Date:  2020-11-02       Impact factor: 4.315

4.  Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia.

Authors:  Maria Moskalenko; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

5.  Matrix Metalloproteinase-2 Polymorphisms and Incident Coronary Artery Disease: A Meta-Analysis.

Authors:  Yujie Shi; Jian Zhang; Chen Tan; Wei Xu; Qi Sun; Junxia Li
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.

Authors:  Soumaya Boumiza; Sarra Bchir; Hela Ben Nasr; Ammar Abbassi; Marie-Paule Jacob; Xavier Norel; Zouhair Tabka; Karim Chahed
Journal:  Dis Markers       Date:  2017-11-26       Impact factor: 3.434

7.  Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.

Authors:  S A Peeters; L Engelen; J Buijs; A Jorsal; H-H Parving; L Tarnow; P Rossing; C G Schalkwijk; C D A Stehouwer
Journal:  Cardiovasc Diabetol       Date:  2017-04-26       Impact factor: 9.951

8.  Investigation of association between genetic polymorphisms of MMP2, MMP8, MMP9 and TIMP2 and development of varicose veins in the Slovak Population - pilot study.

Authors:  J Mazuchová; E Halašová; J Mazuch; M Šarlinová; V Valentová; M Franeková; Š Zelník; K Krkošková; K Javorka; M Péč; M Grendár
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

9.  PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population.

Authors:  Nonanzit Pérez-Hernández; Gilberto Vargas-Alarcón; Rosalinda Posadas-Sánchez; Nancy Martínez-Rodríguez; Carlos Alfonso Tovilla-Zárate; Adrián Asael Rodríguez-Cortés; Oscar Pérez-Méndez; Ruben Blachman-Braun; José Manuel Rodríguez-Pérez
Journal:  Int J Environ Res Public Health       Date:  2016-08-09       Impact factor: 3.390

10.  Risk of macular degeneration affected by polymorphisms in Matrix metalloproteinase-2: A case-control study in Chinese Han population.

Authors:  Jie Cheng; Xiaolin Hao; Zhongchen Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.